| 摘要 |
The present invention provides an inhalation-type pharmaceutical composition for the treatment of Alzheimer′s disease including a first gas and an atomized medicine, and a manufacturing method thereof. The first gas comprises hydrogen. The gas volume concentration of hydrogen in the inhalation-type pharmaceutical composition is 2-96%. The atomized medicine is selected from a group including rivastigmine hydrogen tartrate, donepezil hydrochloride, galantamine hydrobromide, memantine hydrochloride, and any combination thereof. The inhalation-type pharmaceutical composition of the present invention can provide the convenience of taking medicine and removing harmful radicals (active oxygen) in the body of the patient through the use of hydrogen while also increases the absorption effect of the medicine for the patient by using an atomized medicine. Simultaneously, the side effects on the patient can be indirectly reduced by using the small amount of the atomized pharmaceutical liquid. |
